AGP Picks
View all

Wellness Wire Kansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Kansas.

Press releases published on June 9, 2026

A Win for Your Skin: 4 Steps to Support Skin Health
Statewide Summit Focuses on Safer Pain Management  and Healthy Aging for Older Adults
ENT & Allergy Associates and Hümi  Name J.P. Morgan as Primary Bank and Lender
Shades For Migraine Brings Visibility And Validation To Millions
American Kidney Fund Launches Educational Campaign to Increase Awareness and Knowledge of FSGS
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
Press Release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer
Legend Senior Living Earns Great Place to Work® Certification™ for Eighth Consecutive Year
ファーティリティ・インスティテュート・オブ・ハワイ、遺伝子最適化の需要が拡大し続ける中、ニュークレアスIVF+ネットワークに加盟
하와이 최대 IVF 기관, Nucleus IVF+ 네트워크에 합류해 유전 최적화 수요 확대 대응
Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to Expand
AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology
International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje
Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium
Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

Share this page:

Sign up for:

Wellness Wire Kansas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.